Below are the top 10 best-performing U.S.-listed Chinese stocks for the past
week. AutoChina International Limited (NASDAQ:AUTC) was the 1st best-performing
stock last week in this segment of the market. Its weekly performance was 56.03%
for the week. Its price percentage change was -14.96% year-to-date. Trunkbow
International Holdings Ltd (NASDAQ:TBOW) was the 2nd best-performing stock last
week in this segment of the market. Its weekly performance was 31.66% for the
week. Its price percentage change was N/A year-to-date. Jiangbo Pharmaceuticals,
Inc. (NASDAQ:JGBO) was the 3rd best-performing stock last week in this segment
of the market. Its weekly performance was 31.03% for the week. Its price
percentage change was -96.68% year-to-date. Keyuan Petrochemicals, Inc.
(NASDAQ:KEYP) was the 4th best-performing stock last week in this segment of the
market. Its weekly performance was 26.95% for the week. Its price percentage
change was -52.89% year-to-date. Recon Technology, Ltd. (NASDAQ:RCON) was the
5th best-performing stock last week in this segment of the market. Its weekly
performance was 21.05% for the week. Its price percentage change was -80.22%
year-to-date. China Metro Rural Holdings Ltd (AMEX:CNR) was the 6th
best-performing stock last week in this segment of the market. Its weekly
performance was 18.80% for the week. Its price percentage change was -60.00%
year-to-date. Shanda Interactive Entertainment Ltd ADR (NASDAQ:SNDA) was the 7th
best-performing stock last week in this segment of the market. Its weekly
performance was 17.03% for the week. Its price percentage change was -1.16%
year-to-date. China Ming Yang Wind Power Group Ltd (NYSE:MY) was the 8th
best-performing stock last week in this segment of the market. Its weekly
performance was 15.66% for the week. Its price percentage change was -71.74%
year-to-date. China Ceramics Co Ltd (NASDAQ:CCCL) was the 9th best-performing
stock last week in this segment of the market. Its weekly performance was 15.31%
for the week. Its price percentage change was -61.71% year-to-date. Tibet
Pharmaceuticals, Inc. (NASDAQ:TBET) was the 10th best-performing stock last week
in this segment of the market. Its weekly performance was 15.09% for the week.
Its price percentage change was N/A year-to-date.
Saturday, October 22, 2011
Google Alert - antiques coin
| ||
| Strawberry farmers find gold Daily Examiner ... museum of antiques and collectibles they claim is worth more than $1 million. ... Entry to The Island is free of charge but a gold coin donation, ... |
This as-it-happens Google Alert is brought to you by Google.
Delete this alert.
Create another alert.
Manage your alerts.
Top 10 Leisure Services Stocks with Highest Return on Assets: PCLN, MLP, UTA, CTRP, STNR, EXPE, LTM, GOBK, CNK, CHDN (Oct 22, 2011)
Below are the top 10 Leisure Services stocks with highest Return on Assets
ratio (ROA) for the last 12 months. ROA shows a companys efficiency in making
profits from its assets. It is equal to net profits divided by total assets. Two
Chinese companies (UTA, CTRP) are on the list. priceline.com Incorporated
(NASDAQ:PCLN) has the 1st highest Return on Assets in this segment of the
market. Its ROA was 24.80% for the last 12 months. Its Asset Turnover ratio
(revenue divided by assets) was 1.26 for the same period. Maui Land & Pineapple
Co. (NYSE:MLP) has the 2nd highest Return on Assets in this segment of the
market. Its ROA was 17.53% for the last 12 months. Its Asset Turnover ratio
(revenue divided by assets) was 0.36 for the same period. Universal Travel Group
(NYSE:UTA) has the 3rd highest Return on Assets in this segment of the market.
Its ROA was 15.91% for the last 12 months. Its Asset Turnover ratio (revenue
divided by assets) was 1.23 for the same period. Ctrip.com International, Ltd.
(ADR) (NASDAQ:CTRP) has the 4th highest Return on Assets in this segment of the
market. Its ROA was 13.59% for the last 12 months. Its Asset Turnover ratio
(revenue divided by assets) was 0.41 for the same period. Steiner Leisure
Limited (NASDAQ:STNR) has the 5th highest Return on Assets in this segment of
the market. Its ROA was 13.17% for the last 12 months. Its Asset Turnover ratio
(revenue divided by assets) was 1.69 for the same period. Expedia, Inc.
(NASDAQ:EXPE) has the 6th highest Return on Assets in this segment of the
market. Its ROA was 6.04% for the last 12 months. Its Asset Turnover ratio
(revenue divided by assets) was 0.50 for the same period. Life Time Fitness,
Inc. (NYSE:LTM) has the 7th highest Return on Assets in this segment of the
market. Its ROA was 5.20% for the last 12 months. Its Asset Turnover ratio
(revenue divided by assets) was 0.57 for the same period. Globalink Limited
(NASDAQ:GOBK) has the 8th highest Return on Assets in this segment of the
market. Its ROA was 4.38% for the last 12 months. Its Asset Turnover ratio
(revenue divided by assets) was 0.39 for the same period. Cinemark Holdings,
Inc. (NYSE:CNK) has the 9th highest Return on Assets in this segment of the
market. Its ROA was 4.07% for the last 12 months. Its Asset Turnover ratio
(revenue divided by assets) was 0.64 for the same period. Churchill Downs, Inc.
(NASDAQ:CHDN) has the 10th highest Return on Assets in this segment of the
market. Its ROA was 3.87% for the last 12 months. Its Asset Turnover ratio
(revenue divided by assets) was 0.71 for the same period.
ratio (ROA) for the last 12 months. ROA shows a companys efficiency in making
profits from its assets. It is equal to net profits divided by total assets. Two
Chinese companies (UTA, CTRP) are on the list. priceline.com Incorporated
(NASDAQ:PCLN) has the 1st highest Return on Assets in this segment of the
market. Its ROA was 24.80% for the last 12 months. Its Asset Turnover ratio
(revenue divided by assets) was 1.26 for the same period. Maui Land & Pineapple
Co. (NYSE:MLP) has the 2nd highest Return on Assets in this segment of the
market. Its ROA was 17.53% for the last 12 months. Its Asset Turnover ratio
(revenue divided by assets) was 0.36 for the same period. Universal Travel Group
(NYSE:UTA) has the 3rd highest Return on Assets in this segment of the market.
Its ROA was 15.91% for the last 12 months. Its Asset Turnover ratio (revenue
divided by assets) was 1.23 for the same period. Ctrip.com International, Ltd.
(ADR) (NASDAQ:CTRP) has the 4th highest Return on Assets in this segment of the
market. Its ROA was 13.59% for the last 12 months. Its Asset Turnover ratio
(revenue divided by assets) was 0.41 for the same period. Steiner Leisure
Limited (NASDAQ:STNR) has the 5th highest Return on Assets in this segment of
the market. Its ROA was 13.17% for the last 12 months. Its Asset Turnover ratio
(revenue divided by assets) was 1.69 for the same period. Expedia, Inc.
(NASDAQ:EXPE) has the 6th highest Return on Assets in this segment of the
market. Its ROA was 6.04% for the last 12 months. Its Asset Turnover ratio
(revenue divided by assets) was 0.50 for the same period. Life Time Fitness,
Inc. (NYSE:LTM) has the 7th highest Return on Assets in this segment of the
market. Its ROA was 5.20% for the last 12 months. Its Asset Turnover ratio
(revenue divided by assets) was 0.57 for the same period. Globalink Limited
(NASDAQ:GOBK) has the 8th highest Return on Assets in this segment of the
market. Its ROA was 4.38% for the last 12 months. Its Asset Turnover ratio
(revenue divided by assets) was 0.39 for the same period. Cinemark Holdings,
Inc. (NYSE:CNK) has the 9th highest Return on Assets in this segment of the
market. Its ROA was 4.07% for the last 12 months. Its Asset Turnover ratio
(revenue divided by assets) was 0.64 for the same period. Churchill Downs, Inc.
(NASDAQ:CHDN) has the 10th highest Return on Assets in this segment of the
market. Its ROA was 3.87% for the last 12 months. Its Asset Turnover ratio
(revenue divided by assets) was 0.71 for the same period.
Apple’s Buying Event of the Decade: Don’t Miss Out!
XCSFDHG46767FHJHJF
tdp2664 InvestorPlace Christmas and Chanukah came early this year. The Street completely misread Apple's ( NASDAQ : AAPL ) most recent earnings announcement, the stock took a bit of a hit, and now we have the buying opportunity of the year … maybe even the decade. What Apple announced, everyone focused on the word "missed." They missed revenue estimates. They missed profit estimates. But the message from the company that some people missed was, "The whole world was waiting for the new phone. They did not buy as many of the old phones. But now, we are sold out of the new phone and, by the way, we have a free phone for low-end users." In other words, everyone's used to (only) hearing how much Apple "beat" expectations. And true to form, they did plenty of that — the company beat on iPad sales, Mac sales and margin expectations. The physics majors and engineers turned analysts who need to justify their spreadsheets looked at the numbers and sold or said not to buy. And to that, I say, "Thank you for that early holiday gift!" So, is it time to sell or time to buy instead? The iPhone worrywarts need to consider this: A recent survey by ChangeWave Research/451 Group showed enormous pent-up demand for the 4S, and the newest smartphone's sales were more than double that of the iPhone 4 during its own launch period. Plus, the company just opened up pre-orders for the phone in 22 additional countries. There's no doubt that this stock will recover lost ground, and quickly. Of course, that is a response to a short-term worry. What about the longer term? Apple is the world's dominant brand in consumer electronics. So, it has tremendous market share and, therefore, the stock has no room to run, right? Wrong. Here's why: The world market for cell phones of all kinds in 2012 is estimated to be 1.7 billion units. Apple's share estimate? 110 million units, a 6.5% share . The world market for tablets in 2012 is estimated to be 72 million (JPMorgan (NYSE: JPM ) estimates), with Apple selling 45 million to 50 million — a 62% to 69% share. Well, actually, I look at this market as tablets plus their "displacement equivalents" — netbooks and very low-end laptops increasingly displaced by tablets — and I find that market to be roughly 200 million units. So, Apple has only a 25% share . The world market for computers in 2012 is estimated to be about 440 million units (Gartner Group). Apple sold 4 million Macs in Q3; let's say they sell 25 million in 2012 — that is a 5.7% share . Apple is the world's best consumer brand. Its electronic products have the highest level of consumer satisfaction. It's the largest market cap company in the United States. And it has 6.5%, 25% and 5.7% share in its target markets, not to mention margins that are almost double that of their primary competitors. In other words, if you're still wondering whether it's a buy right now, there's the bullish case in a nutshell. If you don't own AAPL already, I recommend that you buy it. (Disclosure: I own it.) Another way to trade it is to buy call options. The January 2012 and the January 2013 calls look good right here. If you buy the out-of-the-money calls — that is, with strike prices above the market price — you get more leverage as it moves up. I also write calls ("Sell to Open") against my long stock all the time. Before the earnings announcement I sold calls, and bought them back when the stock moved down. Doing this month after month (and week after week with AAPL's weekly options) helped me to average down the net cost of my shares roughly $6 a share. The great thing about selling calls against your long stock (i.e., the covered-call strategy) is the income you can bring in on a regular schedule. The covered call isn't a "one and done" strategy – you can keep doing it again and again. That money not only helps bring down your cost average for the shares, but it also ensures that your bottom line keeps growing with every trade. From time to time, however, I'll take some of that cash income out of the markets — I believe it's important to enjoy your returns along the way. Next time I take out some cash, it will probably be to buy a new iPad for my wife for Christmas. Unless they are sold out, of course!
Top 10 IT Services Stocks with Highest Return on Assets: ZIXI, BIDU, CPSI, CNET, TBOW, PNS, MELI, NTES, MAIL, INFY (Oct 22, 2011)
Below are the top 10 IT Services stocks with highest Return on Assets ratio
(ROA) for the last 12 months. ROA shows a companys efficiency in making profits
from its assets. It is equal to net profits divided by total assets. Four
Chinese companies (BIDU, CNET, TBOW, NTES) are on the list. Zix Corporation
(NASDAQ:ZIXI) has the 1st highest Return on Assets in this segment of the
market. Its ROA was 105.70% for the last 12 months. Its Asset Turnover ratio
(revenue divided by assets) was 0.87 for the same period. Baidu.com, Inc. (ADR)
(NASDAQ:BIDU) has the 2nd highest Return on Assets in this segment of the
market. Its ROA was 44.33% for the last 12 months. Its Asset Turnover ratio
(revenue divided by assets) was 0.95 for the same period. Computer Programs &
Systems, Inc. (NASDAQ:CPSI) has the 3rd highest Return on Assets in this segment
of the market. Its ROA was 38.52% for the last 12 months. Its Asset Turnover
ratio (revenue divided by assets) was 2.69 for the same period. Chinanet Online
Holdings Inc (NASDAQ:CNET) has the 4th highest Return on Assets in this segment
of the market. Its ROA was 34.78% for the last 12 months. Its Asset Turnover
ratio (revenue divided by assets) was 0.86 for the same period. Trunkbow
International Holdings Ltd (NASDAQ:TBOW) has the 5th highest Return on Assets in
this segment of the market. Its ROA was 33.51% for the last 12 months. Its Asset
Turnover ratio (revenue divided by assets) was 0.51 for the same period.
Pinnacle Data Systems, Inc. (AMEX:PNS) has the 6th highest Return on Assets in
this segment of the market. Its ROA was 27.44% for the last 12 months. Its Asset
Turnover ratio (revenue divided by assets) was 2.23 for the same period.
MercadoLibre, Inc. (NASDAQ:MELI) has the 7th highest Return on Assets in this
segment of the market. Its ROA was 24.60% for the last 12 months. Its Asset
Turnover ratio (revenue divided by assets) was 0.96 for the same period.
NetEase.com, Inc. (ADR) (NASDAQ:NTES) has the 8th highest Return on Assets in
this segment of the market. Its ROA was 24.06% for the last 12 months. Its Asset
Turnover ratio (revenue divided by assets) was 0.54 for the same period.
IncrediMail Ltd. (USA) (NASDAQ:MAIL) has the 9th highest Return on Assets in
this segment of the market. Its ROA was 23.26% for the last 12 months. Its Asset
Turnover ratio (revenue divided by assets) was 0.79 for the same period. Infosys
Ltd ADR (NASDAQ:INFY) has the 10th highest Return on Assets in this segment of
the market. Its ROA was 23.12% for the last 12 months. Its Asset Turnover ratio
(revenue divided by assets) was 0.96 for the same period.
(ROA) for the last 12 months. ROA shows a companys efficiency in making profits
from its assets. It is equal to net profits divided by total assets. Four
Chinese companies (BIDU, CNET, TBOW, NTES) are on the list. Zix Corporation
(NASDAQ:ZIXI) has the 1st highest Return on Assets in this segment of the
market. Its ROA was 105.70% for the last 12 months. Its Asset Turnover ratio
(revenue divided by assets) was 0.87 for the same period. Baidu.com, Inc. (ADR)
(NASDAQ:BIDU) has the 2nd highest Return on Assets in this segment of the
market. Its ROA was 44.33% for the last 12 months. Its Asset Turnover ratio
(revenue divided by assets) was 0.95 for the same period. Computer Programs &
Systems, Inc. (NASDAQ:CPSI) has the 3rd highest Return on Assets in this segment
of the market. Its ROA was 38.52% for the last 12 months. Its Asset Turnover
ratio (revenue divided by assets) was 2.69 for the same period. Chinanet Online
Holdings Inc (NASDAQ:CNET) has the 4th highest Return on Assets in this segment
of the market. Its ROA was 34.78% for the last 12 months. Its Asset Turnover
ratio (revenue divided by assets) was 0.86 for the same period. Trunkbow
International Holdings Ltd (NASDAQ:TBOW) has the 5th highest Return on Assets in
this segment of the market. Its ROA was 33.51% for the last 12 months. Its Asset
Turnover ratio (revenue divided by assets) was 0.51 for the same period.
Pinnacle Data Systems, Inc. (AMEX:PNS) has the 6th highest Return on Assets in
this segment of the market. Its ROA was 27.44% for the last 12 months. Its Asset
Turnover ratio (revenue divided by assets) was 2.23 for the same period.
MercadoLibre, Inc. (NASDAQ:MELI) has the 7th highest Return on Assets in this
segment of the market. Its ROA was 24.60% for the last 12 months. Its Asset
Turnover ratio (revenue divided by assets) was 0.96 for the same period.
NetEase.com, Inc. (ADR) (NASDAQ:NTES) has the 8th highest Return on Assets in
this segment of the market. Its ROA was 24.06% for the last 12 months. Its Asset
Turnover ratio (revenue divided by assets) was 0.54 for the same period.
IncrediMail Ltd. (USA) (NASDAQ:MAIL) has the 9th highest Return on Assets in
this segment of the market. Its ROA was 23.26% for the last 12 months. Its Asset
Turnover ratio (revenue divided by assets) was 0.79 for the same period. Infosys
Ltd ADR (NASDAQ:INFY) has the 10th highest Return on Assets in this segment of
the market. Its ROA was 23.12% for the last 12 months. Its Asset Turnover ratio
(revenue divided by assets) was 0.96 for the same period.
Best Buy (NYSE:BBY) Lets Users Download Battlefield 3
XCSFDHG46767FHJHJF
tdp2664 E money daily Best Buy (NYSE:BBY) has begun providing early downloads for Battlefield 3. Best Buy (NYSE:BBY) Lets Users Download Battlefield 3 Best Buy (NYSE:BBY) customers who have pre-ordered the digital version of the much awaited game Battlefield 3 can begin the download of the game to their PC early from their account. The company also said that it is offering digital pre-order for the game. The customers will get a code on the day of the game launch and they can start their game instantly. Best Buy (NYSE:BBY) said that the pre-ordered customers will get a discount of 15 percent and Reward Zone points. The company also offers classic Battlefield 2 weapons and vehicles, upgrade to the Limited Edition with bonus content, SPECACT kit upgrade and four legendary maps from Battlefield 2 with the new download Best Buy (NYSE:BBY) shares are currently standing at 25.73. Price History Last Price: 25.73 52 Week Low / High: 21.79 / 45.63 50 Day Moving Average: 24.54 6 Month Price Change %: -16.8% 12 Month Price Change %: -40.4%
Top 10 Investment Services Stocks with Highest Return on Assets: PZN, VALU, DHIL, FNGN, EPHC, CBOE, FDS, CLMS, NOAH, ART (Oct 22, 2011)
XCSFDHG46767FHJHJF
tdp2664 China Analyst Below are the top 10 Investment Services stocks with highest Return on Assets ratio (ROA) for the last 12 months. ROA shows a company's efficiency in making profits from its assets. It is equal to net profits divided by total assets. One Chinese company (NOAH) is on the list. Pzena Investment Management, Inc. (NYSE:PZN) has the 1st highest Return on Assets in this segment of the market. Its ROA was 70.13% for the last 12 months. Its Asset Turnover ratio (revenue divided by assets) was 1.42 for the same period. Value Line, Inc. (NASDAQ:VALU) has the 2nd highest Return on Assets in this segment of the market. Its ROA was 51.88% for the last 12 months. Its Asset Turnover ratio (revenue divided by assets) was 0.61 for the same period. Diamond Hill Investment Group, Inc. (NASDAQ:DHIL) has the 3rd highest Return on Assets in this segment of the market. Its ROA was 37.01% for the last 12 months. Its Asset Turnover ratio (revenue divided by assets) was 1.52 for the same period. Financial Engines Inc (NASDAQ:FNGN) has the 4th highest Return on Assets in this segment of the market. Its ROA was 35.83% for the last 12 months. Its Asset Turnover ratio (revenue divided by assets) was 0.70 for the same period. Epoch Holding Corp (NASDAQ:EPHC) has the 5th highest Return on Assets in this segment of the market. Its ROA was 32.29% for the last 12 months. Its Asset Turnover ratio (revenue divided by assets) was 1.06 for the same period. CBOE Holdings, Inc (NASDAQ:CBOE) has the 6th highest Return on Assets in this segment of the market. Its ROA was 28.02% for the last 12 months. Its Asset Turnover ratio (revenue divided by assets) was 1.11 for the same period. FactSet Research Systems Inc. (NYSE:FDS) has the 7th highest Return on Assets in this segment of the market. Its ROA was 26.27% for the last 12 months. Its Asset Turnover ratio (revenue divided by assets) was 1.12 for the same period. Calamos Asset Management, Inc (NASDAQ:CLMS) has the 8th highest Return on Assets in this segment of the market. Its ROA was 25.94% for the last 12 months. Its Asset Turnover ratio (revenue divided by assets) was 0.62 for the same period. Noah Holdings Limited (ADR) (NYSE:NOAH) has the 9th highest Return on Assets in this segment of the market. Its ROA was 23.23% for the last 12 months. Its Asset Turnover ratio (revenue divided by assets) was 0.66 for the same period. Artio Global Investors Inc. (NYSE:ART) has the 10th highest Return on Assets in this segment of the market. Its ROA was 22.91% for the last 12 months. Its Asset Turnover ratio (revenue divided by assets) was 0.81 for the same period.
IBM (NYSE:IBM) Shows Off Smart Cloud
XCSFDHG46767FHJHJF
tdp2664 E money daily IBM (NYSE:IBM) has announced new smart cloud services. IBM (NYSE:IBM) Shows Off Smart Cloud The tech giant IBM (NYSE:IBM) has announced cloud services and software. With plans to support 200 million users by the end of 2012 on its smart cloud, the company has emphasised its applications led approach. Hardware also got a look in with its foundation kit, but it was in enterprise software that the company believes it has a lead over its rivals. Erich Clementi, senior vice president, IBM (NYSE:IBM), said that, "Enterprise clients are much more conservative because their revenue, reputation and supply chain are closely related to the performance and security of their infrastructure. Our focus with smart cloud will bring the benefits of this model in a way that supports enterprise level service, leverages existing investments and opens new doors to productivity and innovation." IBM (NYSE:IBM) stocks were at 177.25 at the end of the last day’s trading. There’s been a -3.4% movement in the stock price over the past 3 months. IBM (NYSE:IBM) Analyst Advice Consensus Opinion: Moderate Buy Mean recommendation: 1.9 (1=Strong Buy, 5=Strong Sell) 3 Months Ago: 1.91 Zack’s Rank: 2 out of 19 in the industry
Top 10 Industrial Stocks with Highest Return on Assets: VALV, SHS, RAVN, SNHY, LUK, GGG, NDSN, FAST, OYOG, CVVT (Oct 22, 2011)
XCSFDHG46767FHJHJF
tdp2664 China Analyst Below are the top 10 Industrial stocks with highest Return on Assets ratio (ROA) for the last 12 months. ROA shows a company's efficiency in making profits from its assets. It is equal to net profits divided by total assets. Two Chinese companies (VALV, CVVT) are on the list. Shengkai Innovations, Inc. (NASDAQ:VALV) has the 1st highest Return on Assets in this segment of the market. Its ROA was 82.95% for the last 12 months. Its Asset Turnover ratio (revenue divided by assets) was 0.83 for the same period. Sauer-Danfoss Inc. (NYSE:SHS) has the 2nd highest Return on Assets in this segment of the market. Its ROA was 29.23% for the last 12 months. Its Asset Turnover ratio (revenue divided by assets) was 1.67 for the same period. Raven Industries, Inc. (NASDAQ:RAVN) has the 3rd highest Return on Assets in this segment of the market. Its ROA was 23.45% for the last 12 months. Its Asset Turnover ratio (revenue divided by assets) was 1.72 for the same period. Sun Hydraulics Corporation (NASDAQ:SNHY) has the 4th highest Return on Assets in this segment of the market. Its ROA was 22.70% for the last 12 months. Its Asset Turnover ratio (revenue divided by assets) was 1.31 for the same period. Leucadia National Corp. (NYSE:LUK) has the 5th highest Return on Assets in this segment of the market. Its ROA was 22.49% for the last 12 months. Its Asset Turnover ratio (revenue divided by assets) was 0.23 for the same period. Graco Inc. (NYSE:GGG) has the 6th highest Return on Assets in this segment of the market. Its ROA was 21.85% for the last 12 months. Its Asset Turnover ratio (revenue divided by assets) was 1.38 for the same period. Nordson Corporation (NASDAQ:NDSN) has the 7th highest Return on Assets in this segment of the market. Its ROA was 21.61% for the last 12 months. Its Asset Turnover ratio (revenue divided by assets) was 1.16 for the same period. Fastenal Company (NASDAQ:FAST) has the 8th highest Return on Assets in this segment of the market. Its ROA was 21.51% for the last 12 months. Its Asset Turnover ratio (revenue divided by assets) was 1.69 for the same period. OYO Geospace Corporation (NASDAQ:OYOG) has the 9th highest Return on Assets in this segment of the market. Its ROA was 17.46% for the last 12 months. Its Asset Turnover ratio (revenue divided by assets) was 0.99 for the same period. China Valves Technology, Inc. (NASDAQ:CVVT) has the 10th highest Return on Assets in this segment of the market. Its ROA was 17.22% for the last 12 months. Its Asset Turnover ratio (revenue divided by assets) was 0.88 for the same period.
Microsoft Corporation (NASDAQ:MSFT) Donates To Open Source
XCSFDHG46767FHJHJF
tdp2664 E money daily Microsoft Corporation ( NASDAQ :MSFT) has contributed its Biology Project to open source. Microsoft Corporation ( NASDAQ :MSFT) Donates To Open Source It has been reported that Microsoft Corporation ( NASDAQ :MSFT) has contributed its .Net Bio project to the Outercurve Foundation's Research Accelerators Gallery. The Outercurve Foundation is a software IP management and project development governance organization for open-source efforts. Net Bio is a language-neutral, reusable .NET library and API that supports the development of applications for bioinformatics research, and it is the fourth project contributed to the gallery. Tony Hey, an Outercurve board member and corporate vice president of Microsoft Corporation (NASDAQ:MSFT) Research Connections, said that, "As part of the Outercurve Foundation, .Net Bio project committers will have the resources and community participation to support more complex and very large plant genomes by working with universities and consortia around the world. The project brings a strong history of consistent and dedicated community management to the Outercurve Foundation". Microsoft Corp. (NASDAQ:MSFT) shares are currently standing at 27.04. Price History Last Price: 27.04 52 Week Low / High: 23.65 / 29.46 50 Day Moving Average: 25.84 6 Month Price Change %: 5.3% 12 Month Price Change %: 8.1%
Top 10 Investment Services Stocks with Highest Return on Assets: PZN, VALU, DHIL, FNGN, EPHC, CBOE, FDS, CLMS, NOAH, ART (Oct 22, 2011)
Below are the top 10 Investment Services stocks with highest Return on Assets
ratio (ROA) for the last 12 months. ROA shows a companys efficiency in making
profits from its assets. It is equal to net profits divided by total assets. One
Chinese company (NOAH) is on the list. Pzena Investment Management, Inc.
(NYSE:PZN) has the 1st highest Return on Assets in this segment of the market.
Its ROA was 70.13% for the last 12 months. Its Asset Turnover ratio (revenue
divided by assets) was 1.42 for the same period. Value Line, Inc. (NASDAQ:VALU)
has the 2nd highest Return on Assets in this segment of the market. Its ROA was
51.88% for the last 12 months. Its Asset Turnover ratio (revenue divided by
assets) was 0.61 for the same period. Diamond Hill Investment Group, Inc.
(NASDAQ:DHIL) has the 3rd highest Return on Assets in this segment of the
market. Its ROA was 37.01% for the last 12 months. Its Asset Turnover ratio
(revenue divided by assets) was 1.52 for the same period. Financial Engines Inc
(NASDAQ:FNGN) has the 4th highest Return on Assets in this segment of the
market. Its ROA was 35.83% for the last 12 months. Its Asset Turnover ratio
(revenue divided by assets) was 0.70 for the same period. Epoch Holding Corp
(NASDAQ:EPHC) has the 5th highest Return on Assets in this segment of the
market. Its ROA was 32.29% for the last 12 months. Its Asset Turnover ratio
(revenue divided by assets) was 1.06 for the same period. CBOE Holdings, Inc
(NASDAQ:CBOE) has the 6th highest Return on Assets in this segment of the
market. Its ROA was 28.02% for the last 12 months. Its Asset Turnover ratio
(revenue divided by assets) was 1.11 for the same period. FactSet Research
Systems Inc. (NYSE:FDS) has the 7th highest Return on Assets in this segment of
the market. Its ROA was 26.27% for the last 12 months. Its Asset Turnover ratio
(revenue divided by assets) was 1.12 for the same period. Calamos Asset
Management, Inc (NASDAQ:CLMS) has the 8th highest Return on Assets in this
segment of the market. Its ROA was 25.94% for the last 12 months. Its Asset
Turnover ratio (revenue divided by assets) was 0.62 for the same period. Noah
Holdings Limited (ADR) (NYSE:NOAH) has the 9th highest Return on Assets in this
segment of the market. Its ROA was 23.23% for the last 12 months. Its Asset
Turnover ratio (revenue divided by assets) was 0.66 for the same period. Artio
Global Investors Inc. (NYSE:ART) has the 10th highest Return on Assets in this
segment of the market. Its ROA was 22.91% for the last 12 months. Its Asset
Turnover ratio (revenue divided by assets) was 0.81 for the same period.
ratio (ROA) for the last 12 months. ROA shows a companys efficiency in making
profits from its assets. It is equal to net profits divided by total assets. One
Chinese company (NOAH) is on the list. Pzena Investment Management, Inc.
(NYSE:PZN) has the 1st highest Return on Assets in this segment of the market.
Its ROA was 70.13% for the last 12 months. Its Asset Turnover ratio (revenue
divided by assets) was 1.42 for the same period. Value Line, Inc. (NASDAQ:VALU)
has the 2nd highest Return on Assets in this segment of the market. Its ROA was
51.88% for the last 12 months. Its Asset Turnover ratio (revenue divided by
assets) was 0.61 for the same period. Diamond Hill Investment Group, Inc.
(NASDAQ:DHIL) has the 3rd highest Return on Assets in this segment of the
market. Its ROA was 37.01% for the last 12 months. Its Asset Turnover ratio
(revenue divided by assets) was 1.52 for the same period. Financial Engines Inc
(NASDAQ:FNGN) has the 4th highest Return on Assets in this segment of the
market. Its ROA was 35.83% for the last 12 months. Its Asset Turnover ratio
(revenue divided by assets) was 0.70 for the same period. Epoch Holding Corp
(NASDAQ:EPHC) has the 5th highest Return on Assets in this segment of the
market. Its ROA was 32.29% for the last 12 months. Its Asset Turnover ratio
(revenue divided by assets) was 1.06 for the same period. CBOE Holdings, Inc
(NASDAQ:CBOE) has the 6th highest Return on Assets in this segment of the
market. Its ROA was 28.02% for the last 12 months. Its Asset Turnover ratio
(revenue divided by assets) was 1.11 for the same period. FactSet Research
Systems Inc. (NYSE:FDS) has the 7th highest Return on Assets in this segment of
the market. Its ROA was 26.27% for the last 12 months. Its Asset Turnover ratio
(revenue divided by assets) was 1.12 for the same period. Calamos Asset
Management, Inc (NASDAQ:CLMS) has the 8th highest Return on Assets in this
segment of the market. Its ROA was 25.94% for the last 12 months. Its Asset
Turnover ratio (revenue divided by assets) was 0.62 for the same period. Noah
Holdings Limited (ADR) (NYSE:NOAH) has the 9th highest Return on Assets in this
segment of the market. Its ROA was 23.23% for the last 12 months. Its Asset
Turnover ratio (revenue divided by assets) was 0.66 for the same period. Artio
Global Investors Inc. (NYSE:ART) has the 10th highest Return on Assets in this
segment of the market. Its ROA was 22.91% for the last 12 months. Its Asset
Turnover ratio (revenue divided by assets) was 0.81 for the same period.
Google Alert - antiques coin
| ||
| A hidden type of treasure Sunshine Coast Daily ... of antiques and collectibles they claim is worth more than $1 million. ... Entry to The Island is free but a gold coin donation, given to the RSPCA, ... |
Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
Microsoft Corporation (NASDAQ:MSFT) Donates To Open Source
Microsoft Corporation (NASDAQ:MSFT) has contributed its Biology Project to open
source. Microsoft Corporation (NASDAQ:MSFT) Donates To Open Source It has been
reported that Microsoft Corporation (NASDAQ:MSFT) has contributed its .Net Bio
project to the Outercurve Foundation's Research Accelerators Gallery. The
Outercurve Foundation is a software IP management and project development
governance organization for open-source efforts. Net Bio is a language-neutral,
reusable .NET library and API that supports the development of applications for
bioinformatics research, and it is the fourth project contributed to the
gallery. Tony Hey, an Outercurve board member and corporate vice president of
Microsoft Corporation (NASDAQ:MSFT) Research Connections, said that, "As part
of the Outercurve Foundation, .Net Bio project committers will have the
resources and community participation to support more complex and very large
plant genomes by working with universities and consortia around the world. The
project brings a strong history of consistent and dedicated community management
to the Outercurve Foundation". Microsoft Corp. (NASDAQ:MSFT) shares are
currently standing at 27.04. Price History Last Price: 27.04 52 Week Low / High:
23.65 / 29.46 50 Day Moving Average: 25.84 6 Month Price Change %: 5.3% 12 Month
Price Change %: 8.1%
source. Microsoft Corporation (NASDAQ:MSFT) Donates To Open Source It has been
reported that Microsoft Corporation (NASDAQ:MSFT) has contributed its .Net Bio
project to the Outercurve Foundation's Research Accelerators Gallery. The
Outercurve Foundation is a software IP management and project development
governance organization for open-source efforts. Net Bio is a language-neutral,
reusable .NET library and API that supports the development of applications for
bioinformatics research, and it is the fourth project contributed to the
gallery. Tony Hey, an Outercurve board member and corporate vice president of
Microsoft Corporation (NASDAQ:MSFT) Research Connections, said that, "As part
of the Outercurve Foundation, .Net Bio project committers will have the
resources and community participation to support more complex and very large
plant genomes by working with universities and consortia around the world. The
project brings a strong history of consistent and dedicated community management
to the Outercurve Foundation". Microsoft Corp. (NASDAQ:MSFT) shares are
currently standing at 27.04. Price History Last Price: 27.04 52 Week Low / High:
23.65 / 29.46 50 Day Moving Average: 25.84 6 Month Price Change %: 5.3% 12 Month
Price Change %: 8.1%
Apple’s Buying Event of the Decade: Don’t Miss Out!
Christmas and Chanukah came early this year. The Street completely misread
Apple's (NASDAQ: AAPL ) most recent earnings announcement, the stock took a
bit of a hit, and now we have the buying opportunity of the year … maybe even
the decade. What Apple announced, everyone focused on the word "missed."
They missed revenue estimates. They missed profit estimates. But the message
from the company that some people missed was, "The whole world was waiting for
the new phone. They did not buy as many of the old phones. But now, we are sold
out of the new phone and, by the way, we have a free phone for low-end users."
In other words, everyone's used to (only) hearing how much Apple "beat"
expectations. And true to form, they did plenty of that the company beat on
iPad sales, Mac sales and margin expectations. The physics majors and engineers
turned analysts who need to justify their spreadsheets looked at the numbers and
sold or said not to buy. And to that, I say, "Thank you for that early holiday
gift!" So, is it time to sell or time to buy instead? The iPhone worrywarts
need to consider this: A recent survey by ChangeWave Research/451 Group showed
enormous pent-up demand for the 4S, and the newest smartphone's sales were
more than double that of the iPhone 4 during its own launch period. Plus, the
company just opened up pre-orders for the phone in 22 additional countries.
There's no doubt that this stock will recover lost ground, and quickly. Of
course, that is a response to a short-term worry. What about the longer term?
Apple is the world's dominant brand in consumer electronics. So, it has
tremendous market share and, therefore, the stock has no room to run, right?
Wrong. Here's why: The world market for cell phones of all kinds in 2012 is
estimated to be 1.7 billion units. Apple's share estimate? 110 million units,
a 6.5% share . The world market for tablets in 2012 is estimated to be 72
million (JPMorgan (NYSE: JPM ) estimates), with Apple selling 45 million to 50
million a 62% to 69% share. Well, actually, I look at this market as tablets
plus their "displacement equivalents" netbooks and very low-end laptops
increasingly displaced by tablets and I find that market to be roughly 200
million units. So, Apple has only a 25% share . The world market for computers
in 2012 is estimated to be about 440 million units (Gartner Group). Apple sold 4
million Macs in Q3; let's say they sell 25 million in 2012 that is a 5.7%
share . Apple is the world's best consumer brand. Its electronic products have
the highest level of consumer satisfaction. It's the largest market cap
company in the United States. And it has 6.5%, 25% and 5.7% share in its target
markets, not to mention margins that are almost double that of their primary
competitors. In other words, if you're still wondering whether it's a buy
right now, there's the bullish case in a nutshell. If you don't own AAPL
already, I recommend that you buy it. (Disclosure: I own it.) Another way to
trade it is to buy call options. The January 2012 and the January 2013 calls
look good right here. If you buy the out-of-the-money calls that is, with
strike prices above the market price you get more leverage as it moves up. I
also write calls ("Sell to Open") against my long stock all the time. Before
the earnings announcement I sold calls, and bought them back when the stock
moved down. Doing this month after month (and week after week with AAPL's
weekly options) helped me to average down the net cost of my shares roughly $6 a
share. The great thing about selling calls against your long stock (i.e., the
covered-call strategy) is the income you can bring in on a regular schedule. The
covered call isn't a "one and done" strategy – you can keep doing it
again and again. That money not only helps bring down your cost average for the
shares, but it also ensures that your bottom line keeps growing with every
trade. From time to time, however, I'll take some of that cash income out of
the markets I believe it's important to enjoy your returns along the way.
Next time I take out some cash, it will probably be to buy a new iPad for my
wife for Christmas. Unless they are sold out, of course!
Apple's (NASDAQ: AAPL ) most recent earnings announcement, the stock took a
bit of a hit, and now we have the buying opportunity of the year … maybe even
the decade. What Apple announced, everyone focused on the word "missed."
They missed revenue estimates. They missed profit estimates. But the message
from the company that some people missed was, "The whole world was waiting for
the new phone. They did not buy as many of the old phones. But now, we are sold
out of the new phone and, by the way, we have a free phone for low-end users."
In other words, everyone's used to (only) hearing how much Apple "beat"
expectations. And true to form, they did plenty of that the company beat on
iPad sales, Mac sales and margin expectations. The physics majors and engineers
turned analysts who need to justify their spreadsheets looked at the numbers and
sold or said not to buy. And to that, I say, "Thank you for that early holiday
gift!" So, is it time to sell or time to buy instead? The iPhone worrywarts
need to consider this: A recent survey by ChangeWave Research/451 Group showed
enormous pent-up demand for the 4S, and the newest smartphone's sales were
more than double that of the iPhone 4 during its own launch period. Plus, the
company just opened up pre-orders for the phone in 22 additional countries.
There's no doubt that this stock will recover lost ground, and quickly. Of
course, that is a response to a short-term worry. What about the longer term?
Apple is the world's dominant brand in consumer electronics. So, it has
tremendous market share and, therefore, the stock has no room to run, right?
Wrong. Here's why: The world market for cell phones of all kinds in 2012 is
estimated to be 1.7 billion units. Apple's share estimate? 110 million units,
a 6.5% share . The world market for tablets in 2012 is estimated to be 72
million (JPMorgan (NYSE: JPM ) estimates), with Apple selling 45 million to 50
million a 62% to 69% share. Well, actually, I look at this market as tablets
plus their "displacement equivalents" netbooks and very low-end laptops
increasingly displaced by tablets and I find that market to be roughly 200
million units. So, Apple has only a 25% share . The world market for computers
in 2012 is estimated to be about 440 million units (Gartner Group). Apple sold 4
million Macs in Q3; let's say they sell 25 million in 2012 that is a 5.7%
share . Apple is the world's best consumer brand. Its electronic products have
the highest level of consumer satisfaction. It's the largest market cap
company in the United States. And it has 6.5%, 25% and 5.7% share in its target
markets, not to mention margins that are almost double that of their primary
competitors. In other words, if you're still wondering whether it's a buy
right now, there's the bullish case in a nutshell. If you don't own AAPL
already, I recommend that you buy it. (Disclosure: I own it.) Another way to
trade it is to buy call options. The January 2012 and the January 2013 calls
look good right here. If you buy the out-of-the-money calls that is, with
strike prices above the market price you get more leverage as it moves up. I
also write calls ("Sell to Open") against my long stock all the time. Before
the earnings announcement I sold calls, and bought them back when the stock
moved down. Doing this month after month (and week after week with AAPL's
weekly options) helped me to average down the net cost of my shares roughly $6 a
share. The great thing about selling calls against your long stock (i.e., the
covered-call strategy) is the income you can bring in on a regular schedule. The
covered call isn't a "one and done" strategy – you can keep doing it
again and again. That money not only helps bring down your cost average for the
shares, but it also ensures that your bottom line keeps growing with every
trade. From time to time, however, I'll take some of that cash income out of
the markets I believe it's important to enjoy your returns along the way.
Next time I take out some cash, it will probably be to buy a new iPad for my
wife for Christmas. Unless they are sold out, of course!
Top 10 Industrial Stocks with Highest Return on Assets: VALV, SHS, RAVN, SNHY, LUK, GGG, NDSN, FAST, OYOG, CVVT (Oct 22, 2011)
Below are the top 10 Industrial stocks with highest Return on Assets ratio
(ROA) for the last 12 months. ROA shows a companys efficiency in making profits
from its assets. It is equal to net profits divided by total assets. Two Chinese
companies (VALV, CVVT) are on the list. Shengkai Innovations, Inc. (NASDAQ:VALV)
has the 1st highest Return on Assets in this segment of the market. Its ROA was
82.95% for the last 12 months. Its Asset Turnover ratio (revenue divided by
assets) was 0.83 for the same period. Sauer-Danfoss Inc. (NYSE:SHS) has the 2nd
highest Return on Assets in this segment of the market. Its ROA was 29.23% for
the last 12 months. Its Asset Turnover ratio (revenue divided by assets) was
1.67 for the same period. Raven Industries, Inc. (NASDAQ:RAVN) has the 3rd
highest Return on Assets in this segment of the market. Its ROA was 23.45% for
the last 12 months. Its Asset Turnover ratio (revenue divided by assets) was
1.72 for the same period. Sun Hydraulics Corporation (NASDAQ:SNHY) has the 4th
highest Return on Assets in this segment of the market. Its ROA was 22.70% for
the last 12 months. Its Asset Turnover ratio (revenue divided by assets) was
1.31 for the same period. Leucadia National Corp. (NYSE:LUK) has the 5th highest
Return on Assets in this segment of the market. Its ROA was 22.49% for the last
12 months. Its Asset Turnover ratio (revenue divided by assets) was 0.23 for the
same period. Graco Inc. (NYSE:GGG) has the 6th highest Return on Assets in this
segment of the market. Its ROA was 21.85% for the last 12 months. Its Asset
Turnover ratio (revenue divided by assets) was 1.38 for the same period. Nordson
Corporation (NASDAQ:NDSN) has the 7th highest Return on Assets in this segment
of the market. Its ROA was 21.61% for the last 12 months. Its Asset Turnover
ratio (revenue divided by assets) was 1.16 for the same period. Fastenal Company
(NASDAQ:FAST) has the 8th highest Return on Assets in this segment of the
market. Its ROA was 21.51% for the last 12 months. Its Asset Turnover ratio
(revenue divided by assets) was 1.69 for the same period. OYO Geospace
Corporation (NASDAQ:OYOG) has the 9th highest Return on Assets in this segment
of the market. Its ROA was 17.46% for the last 12 months. Its Asset Turnover
ratio (revenue divided by assets) was 0.99 for the same period. China Valves
Technology, Inc. (NASDAQ:CVVT) has the 10th highest Return on Assets in this
segment of the market. Its ROA was 17.22% for the last 12 months. Its Asset
Turnover ratio (revenue divided by assets) was 0.88 for the same period.
(ROA) for the last 12 months. ROA shows a companys efficiency in making profits
from its assets. It is equal to net profits divided by total assets. Two Chinese
companies (VALV, CVVT) are on the list. Shengkai Innovations, Inc. (NASDAQ:VALV)
has the 1st highest Return on Assets in this segment of the market. Its ROA was
82.95% for the last 12 months. Its Asset Turnover ratio (revenue divided by
assets) was 0.83 for the same period. Sauer-Danfoss Inc. (NYSE:SHS) has the 2nd
highest Return on Assets in this segment of the market. Its ROA was 29.23% for
the last 12 months. Its Asset Turnover ratio (revenue divided by assets) was
1.67 for the same period. Raven Industries, Inc. (NASDAQ:RAVN) has the 3rd
highest Return on Assets in this segment of the market. Its ROA was 23.45% for
the last 12 months. Its Asset Turnover ratio (revenue divided by assets) was
1.72 for the same period. Sun Hydraulics Corporation (NASDAQ:SNHY) has the 4th
highest Return on Assets in this segment of the market. Its ROA was 22.70% for
the last 12 months. Its Asset Turnover ratio (revenue divided by assets) was
1.31 for the same period. Leucadia National Corp. (NYSE:LUK) has the 5th highest
Return on Assets in this segment of the market. Its ROA was 22.49% for the last
12 months. Its Asset Turnover ratio (revenue divided by assets) was 0.23 for the
same period. Graco Inc. (NYSE:GGG) has the 6th highest Return on Assets in this
segment of the market. Its ROA was 21.85% for the last 12 months. Its Asset
Turnover ratio (revenue divided by assets) was 1.38 for the same period. Nordson
Corporation (NASDAQ:NDSN) has the 7th highest Return on Assets in this segment
of the market. Its ROA was 21.61% for the last 12 months. Its Asset Turnover
ratio (revenue divided by assets) was 1.16 for the same period. Fastenal Company
(NASDAQ:FAST) has the 8th highest Return on Assets in this segment of the
market. Its ROA was 21.51% for the last 12 months. Its Asset Turnover ratio
(revenue divided by assets) was 1.69 for the same period. OYO Geospace
Corporation (NASDAQ:OYOG) has the 9th highest Return on Assets in this segment
of the market. Its ROA was 17.46% for the last 12 months. Its Asset Turnover
ratio (revenue divided by assets) was 0.99 for the same period. China Valves
Technology, Inc. (NASDAQ:CVVT) has the 10th highest Return on Assets in this
segment of the market. Its ROA was 17.22% for the last 12 months. Its Asset
Turnover ratio (revenue divided by assets) was 0.88 for the same period.
8 Dividend-Focused ETFs for Income and Hefty Yields
XCSFDHG46767FHJHJF
tdp2664 InvestorPlace Dividend stocks always have been viewed as a safe haven for investors during volatile economic times because they can deliver income, long-term growth and a hedge against inflation. Lately, dividend-focused exchange-traded funds have grown in popularity because they provide greater diversification and fewer headaches picking individual stocks. Like all ETFs, dividend ETFs are comprised of a basket of equities that trades over an exchange just like a stock. Expenses typically are lower than those associated with mutual funds and can be an even better value if you use a low-cost broker. But dividend ETFs differ significantly, and performance can vary substantially based on the fund's strategy. Dividend ETFs tend to fall into two broad categories: dividend growth ETFs and high dividend yield ETFs — and the similarities between these two types of funds pretty much ends with the words "dividend" and "ETF.” Dividend growth ETFs tend to be safer because they're comprised of high-quality names with comparatively lackluster current yields — often less than 3%. The upside: Those yields tend to be secure and reliable, and their growth rate increases over time. So if you value stable, consistent income above all else, dividend growth ETFs might be for you. High dividend yield ETFs are polar opposites. They focus on delivering eye-popping dividend yields of 9% to 10% or higher. But the price of those yields is greater risk: High dividend yields often are the cost of doing business for baskets of stocks that promise splashy current returns, regardless of their payout history. So if it matters most that your dividend ETF show you the money now, high dividend yield ETFs might be up your alley. Here are four dividend ETFs for conservative income investors and four for investors looking to score the heftiest current yields:
Gold and Silver Ended the week Rising –Daily Recap October 21
XCSFDHG46767FHJHJF
DG365FD46564GFH654FU898 Gold and silver prices changed direction and after sharply declining throughout the week they have bounced back and closed the week rising; crude oil prices continued to trade with mixed trend as WTI oil price inclined and Brent oil slipped; natural gas prices changed also direction and sharply declined. Here is a summary of the price movements of precious metals and energy commodities for October 21st: Precious Metals prices: Gold price sharply increased by 1.44% and reached $1,636; Silver price also rose by 3.01% to reach $31.19. During October, gold price inclined by 0.9% and silver price increased by 3.7%.
Amgen Leads Firms In Pancreatic Cancer Drug Chase
XCSFDHG46767FHJHJF
tdp2664 InvestorPlace Amgen ( Nasdaq : AMGN ) is among several pharmaceutical companies working on a treatment for pancreatic cancer, the deadly disease that recently felled both Steve Jobs of Apple ( Nasdaq : AAPL ) and Nobel Prize-winning immunology expert Ralph Steinman. Amgen is partnered with Japan’s Takeda on development of a drug called ganitumab, which is a monoclonal antibody designed to block a chemical signal that allows tumors to grow unimpeded. The drug targets type 1 insulin-like growth factor receptor (IGF-1R), which is vital to the regulation of cell growth and survival. Amgen researchers hope that by suppressing IGF-1R they can slow the growth of pancreatic cancer tumors and increase overall survival in patients. Amgen started a Phase III study of ganitumab earlier this year. Results of the 825-patient trial are due in October 2013. The drug also is in earlier stages of testing for a variety of other cancers. In a mid-stage study, patients who received the Amgen medication in addition to standard pancreatic cancer therapy gemcitabine had an overall survival rate of 57% after 6 months, compared to 50% with gemcitabine alone. Gemcitabine was discovered and developed by Eli Lilly (NYSE: LLY ), although it is now generic. About 40,000 cases of pancreatic cancer occur annually in the U.S., and nearly as many people will die of the disease this year. Worldwide, it's the fourth-most common cause of cancer death. Survival rates are poor: for all stages combined, the one- and 5-year relative survival rates are 25% and 6%, respectively. For locally advanced and for mestatic pancreatic cancer, which accounts for more than 80% of cases, survival is about 10 and 6 months, respectively. Surgery is often not an option for patients with the tumors, given that most cases aren’t discovered early enough, and only about one out of four patients can count on gemcitabine to help their fight against the cancer, according to data from PubMed Health. Other firms working on superior treatments against this deadly killer include: • Korea-based developer KAEL-GemVax, with funding from Cancer Research UK. The company has a vaccine, called GV1001, which is currently in late-stage clinical trials at 53 hospitals in the U.K. It is being tested on patients with metastatic pancreatic cancer. • NewLink Genetics is attempting to harness the immune system to attack pancreatic cancer with a late-stage vaccine called HyperAcute Pancreas cancer immunotherapy. The Ames, Iowa-based developer is conducting a Phase III trial to evaluate its vaccine in approximately 700 Stage I and Stage II prostate cancer patients. NewLink has received FDA Fast Track and Orphan Drug designations for adjuvant treatment of pancreatic cancer after surgeries to remove tumor tissue. • GlobeImmune, a Louisville, Colo.-based biopharmaceutical firm with a wealth of high-profile investors, is developing a vaccine that targets pancreatic cancer caused by mutated versions of a specific protein. • Cambridge, Mass.-based Merrimack Pharmaceuticals is testing a formulation of the approved chemo drug irinotecan that is encapsulated in tiny liposomal particles to improve its properties for fighting cancer. In a recent Phase II trial, 40 pancreatic cancer patients on the drug had a median overall survival of 22.4 weeks. And one in 5 survived for more than a year, according to the company.
Gold & Silver Prices | Weekly Recap 17-21 October
XCSFDHG46767FHJHJF
DG365FD46564GFH654FU898 Gold and silver prices changed direction from the slow climb up the ladder they have experienced in the first couple of weeks of October as they declined during most of last week. The speculation revolving the next move of the EU policymakers next week may have contributed to the volatility of precious metals’ prices. Some speculate that the liquidity problem many European banks are facing caused them to trade in their commodities’ holding including in gold and silver in order to boost their capital buffer. The Philly Fed Manufacturing Index sharply inclined during October and the U.S. housing starts also picked up in September; these news items may have also helped relieve some of the tension in the financial markets and thus cool the recent gains in the bullion markets.
Gold & Silver Prices | Weekly Recap 17-21 October
Gold and silver prices changed direction from the slow climb up the ladder they
have experienced in the first couple of weeks of October as they declined during
most of last week. The speculation revolving the next move of the EU
policymakers next week may have contributed to the volatility of precious metals
prices. Some speculate that the liquidity problem many European banks are facing
caused them to trade in their commodities holding including in gold and silver
in order to boost their capital buffer. The Philly Fed Manufacturing Index
sharply inclined during October and the U.S. housing starts also picked up in
September; these news items may have also helped relieve some of the tension in
the financial markets and thus cool the recent gains in the bullion markets.
have experienced in the first couple of weeks of October as they declined during
most of last week. The speculation revolving the next move of the EU
policymakers next week may have contributed to the volatility of precious metals
prices. Some speculate that the liquidity problem many European banks are facing
caused them to trade in their commodities holding including in gold and silver
in order to boost their capital buffer. The Philly Fed Manufacturing Index
sharply inclined during October and the U.S. housing starts also picked up in
September; these news items may have also helped relieve some of the tension in
the financial markets and thus cool the recent gains in the bullion markets.
Amgen Leads Firms In Pancreatic Cancer Drug Chase
Amgen (Nasdaq: AMGN ) is among several pharmaceutical companies working on a
treatment for pancreatic cancer, the deadly disease that recently felled both
Steve Jobs of Apple (Nasdaq: AAPL ) and Nobel Prize-winning immunology expert
Ralph Steinman. Amgen is partnered with Japans Takeda on development of a drug
called ganitumab, which is a monoclonal antibody designed to block a chemical
signal that allows tumors to grow unimpeded. The drug targets type 1
insulin-like growth factor receptor (IGF-1R), which is vital to the regulation
of cell growth and survival. Amgen researchers hope that by suppressing IGF-1R
they can slow the growth of pancreatic cancer tumors and increase overall
survival in patients. Amgen started a Phase III study of ganitumab earlier this
year. Results of the 825-patient trial are due in October 2013. The drug also is
in earlier stages of testing for a variety of other cancers. In a mid-stage
study, patients who received the Amgen medication in addition to standard
pancreatic cancer therapy gemcitabine had an overall survival rate of 57% after
6 months, compared to 50% with gemcitabine alone. Gemcitabine was discovered and
developed by Eli Lilly (NYSE: LLY ), although it is now generic. About 40,000
cases of pancreatic cancer occur annually in the U.S., and nearly as many people
will die of the disease this year. Worldwide, it's the fourth-most common
cause of cancer death. Survival rates are poor: for all stages combined, the
one- and 5-year relative survival rates are 25% and 6%, respectively. For
locally advanced and for mestatic pancreatic cancer, which accounts for more
than 80% of cases, survival is about 10 and 6 months, respectively. Surgery is
often not an option for patients with the tumors, given that most cases arent
discovered early enough, and only about one out of four patients can count on
gemcitabine to help their fight against the cancer, according to data from
PubMed Health. Other firms working on superior treatments against this deadly
killer include: • Korea-based developer KAEL-GemVax, with funding from Cancer
Research UK. The company has a vaccine, called GV1001, which is currently in
late-stage clinical trials at 53 hospitals in the U.K. It is being tested on
patients with metastatic pancreatic cancer. • NewLink Genetics is attempting
to harness the immune system to attack pancreatic cancer with a late-stage
vaccine called HyperAcute Pancreas cancer immunotherapy. The Ames, Iowa-based
developer is conducting a Phase III trial to evaluate its vaccine in
approximately 700 Stage I and Stage II prostate cancer patients. NewLink has
received FDA Fast Track and Orphan Drug designations for adjuvant treatment of
pancreatic cancer after surgeries to remove tumor tissue. • GlobeImmune, a
Louisville, Colo.-based biopharmaceutical firm with a wealth of high-profile
investors, is developing a vaccine that targets pancreatic cancer caused by
mutated versions of a specific protein. • Cambridge, Mass.-based Merrimack
Pharmaceuticals is testing a formulation of the approved chemo drug irinotecan
that is encapsulated in tiny liposomal particles to improve its properties for
fighting cancer. In a recent Phase II trial, 40 pancreatic cancer patients on
the drug had a median overall survival of 22.4 weeks. And one in 5 survived for
more than a year, according to the company.
treatment for pancreatic cancer, the deadly disease that recently felled both
Steve Jobs of Apple (Nasdaq: AAPL ) and Nobel Prize-winning immunology expert
Ralph Steinman. Amgen is partnered with Japans Takeda on development of a drug
called ganitumab, which is a monoclonal antibody designed to block a chemical
signal that allows tumors to grow unimpeded. The drug targets type 1
insulin-like growth factor receptor (IGF-1R), which is vital to the regulation
of cell growth and survival. Amgen researchers hope that by suppressing IGF-1R
they can slow the growth of pancreatic cancer tumors and increase overall
survival in patients. Amgen started a Phase III study of ganitumab earlier this
year. Results of the 825-patient trial are due in October 2013. The drug also is
in earlier stages of testing for a variety of other cancers. In a mid-stage
study, patients who received the Amgen medication in addition to standard
pancreatic cancer therapy gemcitabine had an overall survival rate of 57% after
6 months, compared to 50% with gemcitabine alone. Gemcitabine was discovered and
developed by Eli Lilly (NYSE: LLY ), although it is now generic. About 40,000
cases of pancreatic cancer occur annually in the U.S., and nearly as many people
will die of the disease this year. Worldwide, it's the fourth-most common
cause of cancer death. Survival rates are poor: for all stages combined, the
one- and 5-year relative survival rates are 25% and 6%, respectively. For
locally advanced and for mestatic pancreatic cancer, which accounts for more
than 80% of cases, survival is about 10 and 6 months, respectively. Surgery is
often not an option for patients with the tumors, given that most cases arent
discovered early enough, and only about one out of four patients can count on
gemcitabine to help their fight against the cancer, according to data from
PubMed Health. Other firms working on superior treatments against this deadly
killer include: • Korea-based developer KAEL-GemVax, with funding from Cancer
Research UK. The company has a vaccine, called GV1001, which is currently in
late-stage clinical trials at 53 hospitals in the U.K. It is being tested on
patients with metastatic pancreatic cancer. • NewLink Genetics is attempting
to harness the immune system to attack pancreatic cancer with a late-stage
vaccine called HyperAcute Pancreas cancer immunotherapy. The Ames, Iowa-based
developer is conducting a Phase III trial to evaluate its vaccine in
approximately 700 Stage I and Stage II prostate cancer patients. NewLink has
received FDA Fast Track and Orphan Drug designations for adjuvant treatment of
pancreatic cancer after surgeries to remove tumor tissue. • GlobeImmune, a
Louisville, Colo.-based biopharmaceutical firm with a wealth of high-profile
investors, is developing a vaccine that targets pancreatic cancer caused by
mutated versions of a specific protein. • Cambridge, Mass.-based Merrimack
Pharmaceuticals is testing a formulation of the approved chemo drug irinotecan
that is encapsulated in tiny liposomal particles to improve its properties for
fighting cancer. In a recent Phase II trial, 40 pancreatic cancer patients on
the drug had a median overall survival of 22.4 weeks. And one in 5 survived for
more than a year, according to the company.
Gold and Silver Ended the week Rising –Daily Recap October 21
Gold and silver prices changed direction and after sharply declining throughout
the week they have bounced back and closed the week rising; crude oil prices
continued to trade with mixed trend as WTI oil price inclined and Brent oil
slipped; natural gas prices changed also direction and sharply declined. Here is
a summary of the price movements of precious metals and energy commodities for
October 21st: Precious Metals prices: Gold price sharply increased by 1.44% and
reached $1,636; Silver price also rose by 3.01% to reach $31.19. During October,
gold price inclined by 0.9% and silver price increased by 3.7%.
the week they have bounced back and closed the week rising; crude oil prices
continued to trade with mixed trend as WTI oil price inclined and Brent oil
slipped; natural gas prices changed also direction and sharply declined. Here is
a summary of the price movements of precious metals and energy commodities for
October 21st: Precious Metals prices: Gold price sharply increased by 1.44% and
reached $1,636; Silver price also rose by 3.01% to reach $31.19. During October,
gold price inclined by 0.9% and silver price increased by 3.7%.
Todays Gold price per ounce rates Spot gold price per gram; Silver spot price per ounce Current Gold Rates News Today
XCSFDHG46767FHJHJF
dow2664 Gold Futures for December delivery had a positive outing during the last trading session in the USA. Gold price per ounce rates notched higher. Silver price per ounce rates notched higher. The primary stock index composites finished the day higher overall as well. Stock indices in the U.S. reached two month highs. It was a positive day in the marketplace all around. The dollar did however finish the last session lower versus a handful of other currencies. The dollar dropped to the euro, British pound and the Japanese yen. The weaker dollar correlates with the increase in gold acquisition. Gold rates have been trending lower over the course of the past several weeks and investors are beginning to take notice. Bargain hunters are looking towards the precious yellow metal and investors positioned with the yellow metal last session. End of day close for December delivery gold contract was higher by 1.44 percent or 23.20 at 1636.10 per troy ounce. Silver contract for December delivery closed out higher by 3.01 percent or .912 at 31.19 per troy ounce. Spot gold price per gram tracked higher after hours by .93 at 52.79 and spot silver price per ounce was higher by 1.05 at 31.33. Camillo Zucari
Todays DJIA Dow Jones Industrial Average Index DJX DJI, Nasdaq Index, S&P 500 Index Stock Market Investing News Close
XCSFDHG46767FHJHJF
dow2664 The primary index composites in the U.S. moved through positive territory during the majority of the last trading session this week. Trends have been choppy as the affects of global economic developments continue to influence. The ongoing debt resolution process in the eurozone is highly influential and currently, European leaders are suggesting that several more meetings are necessary prior to action plan details being released. The waiting process continues but in the meantime, the primary European indices closed out their last session of the week green. This positively skewed action helped push index trends in the U.S. higher. Stocks were in rally mode throughout Friday’s session. Investors were feeling more optimistic on a global scale. Adding to the positive tone of the day were the better than expected crop of earnings reports. Companies such as McDonald’s and Harman International released positive earnings reports which continue to stoke the stock rally movement. McDonald’s stock pushed higher by over 3.5 percent after news spread of the better-than-expected earning results. The indices closed out officially on the positive side of break-even. The Dow Jones Industrial Average finished higher by 2.31 percent at 11,808.79. The Nasdaq finished higher 1.49 percent at 2,637.46. The S&P 500 closed out the session higher by 1.88 percent at 1,238.25. The dollar dropped versus the euro, British pound and the Japanese yen. Oil price per barrel gained 1.6 percent and gold price per ounce moved higher by 1.4 percent. Frank Matto
Todays Gold price per ounce rates Spot gold price per gram; Silver spot price per ounce Current Gold Rates News Today
Gold Futures for December delivery had a positive outing during the last
trading session in the USA. Gold price per ounce rates notched higher. Silver
price per ounce rates notched higher. The primary stock index composites
finished the day higher overall as well. Stock indices in the U.S. reached two
month highs. It was a positive day in the marketplace all around. The dollar did
however finish the last session lower versus a handful of other currencies. The
dollar dropped to the euro, British pound and the Japanese yen. The weaker
dollar correlates with the increase in gold acquisition. Gold rates have been
trending lower over the course of the past several weeks and investors are
beginning to take notice. Bargain hunters are looking towards the precious
yellow metal and investors positioned with the yellow metal last session. End of
day close for December delivery gold contract was higher by 1.44 percent or
23.20 at 1636.10 per troy ounce. Silver contract for December delivery closed
out higher by 3.01 percent or .912 at 31.19 per troy ounce. Spot gold price per
gram tracked higher after hours by .93 at 52.79 and spot silver price per ounce
was higher by 1.05 at 31.33. Camillo Zucari
trading session in the USA. Gold price per ounce rates notched higher. Silver
price per ounce rates notched higher. The primary stock index composites
finished the day higher overall as well. Stock indices in the U.S. reached two
month highs. It was a positive day in the marketplace all around. The dollar did
however finish the last session lower versus a handful of other currencies. The
dollar dropped to the euro, British pound and the Japanese yen. The weaker
dollar correlates with the increase in gold acquisition. Gold rates have been
trending lower over the course of the past several weeks and investors are
beginning to take notice. Bargain hunters are looking towards the precious
yellow metal and investors positioned with the yellow metal last session. End of
day close for December delivery gold contract was higher by 1.44 percent or
23.20 at 1636.10 per troy ounce. Silver contract for December delivery closed
out higher by 3.01 percent or .912 at 31.19 per troy ounce. Spot gold price per
gram tracked higher after hours by .93 at 52.79 and spot silver price per ounce
was higher by 1.05 at 31.33. Camillo Zucari
Subscribe to:
Posts (Atom)
LinkWithin
